World Journal of Pediatrics

, Volume 9, Issue 1, pp 9–16

Updated diagnosis and treatment of childhood tuberculosis

  • Shou-Chien Chen
  • Kwo-Liang Chen
  • Kou-Huang Chen
  • Shun-Tien Chien
  • Kow-Tong Chen
Review article

Abstract

Background

Childhood tuberculosis (TB) accounts for a significant proportion of the global tuberculosis disease burden. However, current and previous efforts to develop better diagnostic, therapeutic, and preventive interventions have focused on TB in adults, and childhood TB has been relatively neglected. The purpose of this review is to provide an update on the diagnostic and therapeutic recommendations for childhood TB with an emphasis on intrathoracic disease.

Data sources

The literature from a range of sources was reviewed and synthesized to provide an overview of the contemporary approaches for the diagnosis and treatment of childhood TB.

Results

This review summarizes the clinical, radiological, bacteriological, and immunological approaches to diagnose TB infection and disease in children. In addition, we summarize the updated guidelines for the treatment of TB in children.

Conclusions

The development of better diagnostic and therapeutic methods for childhood TB remains a significant challenge. As the strategies for diagnosis and treatment of childhood TB continue to improve and the knowledge base increases, the implementation of these strategies will be crucial.

Key words

childhood diagnosis treatment tuberculosis 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    WHO Report. Global tuberculosis control. Epidemiology, strategy, financing. Geneva: World Health Organization, 2009.Google Scholar
  2. 2.
    Newton SM, Brent AJ, Anderson S, Whittaker E, Kampmann B. Paediatric tuberculosis. Lancet Infect Dis 2008;8:498–510.PubMedCrossRefGoogle Scholar
  3. 3.
    Nelson LJ, Wells CD. Global epidemiology of childhood tuberculosis. Int J Tuberc Lung Dis 2004;8:636–647.PubMedGoogle Scholar
  4. 4.
    Lu TH, Huang RM, Chang TD, Tsao SM, Wu TC. Tuberculosis mortality trends in Taiwan: a resurgence of non-respiratory tuberculosis. Int J Tuberc Lung Dis 2005;9:105–110.PubMedGoogle Scholar
  5. 5.
    Yeh YP, Chang HJ, Yang J, Chang SH, Suo J, Chen TH. Incidence of tuberculosis in mountain areas and surrounding townships: dose-response relationship by geographic analysis. Ann Epidemiol 2005;15:526–532.PubMedCrossRefGoogle Scholar
  6. 6.
    Marais BJ, Obihara CC, Warren RM, Schaaf HS, Gie RP, Donald PR. The burden of childhood tuberculosis: a public health perspective. Int J Tuberc Lung Dis 2005;9:1305–1313.PubMedGoogle Scholar
  7. 7.
    Marais BJ. Childhood tuberculosis: epidemiology and natural history of disease. Indian J Pediatr 2011;78:321–327.PubMedCrossRefGoogle Scholar
  8. 8.
    Yu MC, Suo J, Huang C, Bai KJ, Lin TP, Luh KT. Annual risk of tuberculous infection in Taiwan, 1996–1998. J Formos Med Assoc 1999;98:496–499.PubMedGoogle Scholar
  9. 9.
    Marais BJ, Gie RP, Hesseling AC, Schaaf HS, Lombard C, Enarson DA, et al. A refined symptom-based approach to diagnose pulmonary tuberculosis in children. Pediatrics 2006;118:e1350–1359.PubMedCrossRefGoogle Scholar
  10. 10.
    Hsu KH. Tuberculin reaction in children treated with isoniazid. Am J Dis Child 1983;137:1090–1092.PubMedGoogle Scholar
  11. 11.
    Chan PC, Chang LY, Wu YC, Lu CY, Kuo HS, Lee CY, et al. Age-specific cut-offs for the tuberculin skin test to detect latent tuberculosis in BCG-vaccinated children. Int J Tuberc Lung Dis 2008;12:1401–1406.PubMedGoogle Scholar
  12. 12.
    Wang PD. Assessment of the need for universal BCG vaccination of children in Taipei. Public Health 2009;123:74–77.PubMedCrossRefGoogle Scholar
  13. 13.
    Bowerman RJ. Tuberculin skin testing in BCG-vaccinated populations of adults and children at high risk for tuberculosis in Taiwan. Int J Tuberc Lung Dis 2004;8:1228–1233.PubMedGoogle Scholar
  14. 14.
    Chadha VK. Tuberculin test. Indian J Pediatr 2001;68:53–58.PubMedCrossRefGoogle Scholar
  15. 15.
    Araujo Z, de Waard JH, de Larrea CF, Borges R, Convit J. The effect of Bacille Calmette-Guérin vaccine on tuberculin reactivity in indigenous children from communities with high prevalence of tuberculosis. Vaccine 2008;26:5575–5581.PubMedCrossRefGoogle Scholar
  16. 16.
    Piñeiro R, Mellado MJ, Cilleruelo MJ, García-Ascaso M, Medina-Claros A, García-Hortelano M. Tuberculin skin test in bacille Calmette-Guérin vaccinated children: How should we interpret the results? Eur J Pediatr 2012;171:1625–1632.PubMedCrossRefGoogle Scholar
  17. 17.
    Wang L, Turner MO, Elwood RK, Schulzer M, FitzGerald JM. A meta-analysis of the effect of Bacille Calmette Guérin vaccination on tuberculin skin test measurements. Thorax 2002;57:804–809.PubMedCrossRefGoogle Scholar
  18. 18.
    Joint Tuberculosis Committee of the British Thoracic Society. Chemotherapy and management of tuberculosis in the United Kingdom: recommendation 1998. Thorax 1998;53:536–548.CrossRefGoogle Scholar
  19. 19.
    Guidance for national tuberculosis programmes on the management of tuberculosis in children. Chapter 1: introduction and diagnosis of tuberculosis in children. Int J Tuberc Lung Dis 2006;10:1091–1097.Google Scholar
  20. 20.
    Centers for Disease Control. Taiwan Guidelines for TB Diagnosis and Treatment. Centers for Disease Control, Taiwan, 2011.Google Scholar
  21. 21.
    Starke JR, Taylor-Watts KT. Tuberculosis in the pediatric population of Houston, Texas. Pediatrics 1989;84:28–35.PubMedGoogle Scholar
  22. 22.
    Piñeiro R, Cilleruelo MJ, Mellado MJ. Indications and interpretation of tuberculin skin test. Form Act Pediatr Aten Prim 2010;3:114–116.Google Scholar
  23. 23.
    Piñeiro R, Cilleruelo MJ, García-Hortelano M, García-Ascaso M, Medina-Claros A, Mellado MJ. Effect of nutritional status on tuberculin skin testing. Indian J Pediatr 2012; DOI:10.1007/ s12098-012-0773-1.Google Scholar
  24. 24.
    Piñeiro-Pérez R, García-Hortelano M, Mellado MJ, García-Ascaso M, Medina-Claros A, Fernández N, et al. Is there interference in the interpretation of the tuberculin skin test in children with intestinal parasitic infestation? Pathog Glob Health 2012;3:172–176.CrossRefGoogle Scholar
  25. 25.
    Larsson LO, Bentzon MW, Lind A, Magnusson M, Sandegård G, Skoogh BE, et al. Sensitivity to sensitins and tuberculin in Swedish children. Part 5: A study of school children in an inland rural area. Tuber Lung Dis 1993;74:371–376.PubMedCrossRefGoogle Scholar
  26. 26.
    Sepulveda RL, Burr C, Ferrer X, Sorensen RU. Booster effect of tuberculin testing in healthy 6-year-old school children vaccinated with Bacillus Calmette-Guérin at birth in Santiago, Chile. Pediatr Infect Dis J 1988;7:578–581.PubMedGoogle Scholar
  27. 27.
    Arend SM, Thijsen SF, Leyten EM, Bouwman JJ, Franken WP, Koster BF, et al. Comparison of two interferon-gamma assays and tuberculin skin test for tracing tuberculosis contacts. Am J Respir Crit Care Med 2007;175:618–627.PubMedCrossRefGoogle Scholar
  28. 28.
    Detjen AK, Keil T, Roll S, Hauer B, Mauch H, Wahn U, et al. Interferon-gamma release assays improve the diagnosis of tuberculosis and nontuberculous mycobacterial disease in children in a country with a low incidence of tuberculosis. Clin Infect Dis 2007;45:322–328.PubMedCrossRefGoogle Scholar
  29. 29.
    Cordova J, Shiloh R, Gilman RH, Sheen P, Martin L, Arenas F, et al. Evaluation of molecular tools for detection and drug susceptibility testing of Mycobacterium tuberculosis in stool specimens from patients with pulmonary tuberculosis. J Clin Microbiol 2010;48:1820–1826.PubMedCrossRefGoogle Scholar
  30. 30.
    Méndez-Echevarria A, González-Muñoz M, Mellado MJ, Baquero-Artigao F, Vecino R, Pérez E, et al. Optimizing interpretation of the tuberculin test using an interferon-gamma release assay as a reference standard. Pediatr Infect Dis J 2011;30:426–428.PubMedCrossRefGoogle Scholar
  31. 31.
    Haustein T, Ridout DA, Hartley JC, Thaker U, Shingadia D, Klein NJ, et al. The likelihood of an indeterminate test result from a whole-blood interferon-gamma release assay for the diagnosis of Mycobacterium tuberculosis infection in children correlates with age and immune status. Pediatr Infect Dis J 2009;28:669–673.PubMedCrossRefGoogle Scholar
  32. 32.
    Diel R, Loddenkemper R, Nienhaus A. Evidence-based comparison of commercial interferon-gamma release assays for detecting active TB: a metaanalysis. Chest 2010;137:952–968.PubMedCrossRefGoogle Scholar
  33. 33.
    Bergamini BM, Losi M, Vaienti F, D’Amico R, Meccugni B, Meacci M, et al. Performance of commercial blood tests for the diagnosis of latent tuberculosis infection in children and adolescents. Pediatrics 2009;123:e419–424.PubMedCrossRefGoogle Scholar
  34. 34.
    Rangaka MX, Wilkinson KA, Seldon R, Van Cutsem G, Meintjes GA, Morroni C, et al. Effect of HIV-1 infection on T-Cell-based and skin test detection of tuberculosis infection. Am J Respir Crit Care Med 2007;175:514–520.PubMedCrossRefGoogle Scholar
  35. 35.
    Gennaro ML. Immunologic diagnosis of tuberculosis. Clin Infect Dis 2000;30:S243–S246.PubMedCrossRefGoogle Scholar
  36. 36.
    Nakamura RM, Einck L, Velmonte MA, Kawajiri K, Ang CF, Delasllagas CE, et al. Detection of active tuberculosis by an MPB-64 transdermal patch: a field study. Scand J Infect Dis 2001;33:405–407.PubMedCrossRefGoogle Scholar
  37. 37.
    Boehme C, Molokova E, Minja F, Geis S, Loscher T, Maboko L, et al. Detection of mycobacterial lipoarabinomannan with an antigen-capture ELISA in unprocessed urine of Tanzanian patients with suspected tuberculosis. Trans R Soc Trop Med Hyg 2005;99:893–900.PubMedCrossRefGoogle Scholar
  38. 38.
    Steingart KR, Henry M, Laal S, Hopewell PC, Ramsay A, Menzies D, et al. A systematic review of commercial serological antibody detection tests for the diagnosis of extrapulmonary tuberculosis. Thorax 2007;62:911–918.PubMedGoogle Scholar
  39. 39.
    Mutetwa R, Boehme C, Dimairo M, Bandason T, Munyati SS, Mangwanya D, et al. Diagnostic accuracy of commercial urinary lipoarabinomannan detection in African tuberculosis suspects and patients. Int J Tuberc Lung Dis 2009;13:1253–1259.PubMedGoogle Scholar
  40. 40.
    Starke JR. Diagnosis of tuberculosis in children. Pediatr Infect Dis J 2000;19:1095–1096.PubMedCrossRefGoogle Scholar
  41. 41.
    Marais BJ, Gie RP, Hesseling AC, Schaaf HS, Lombard C, Enarson DA, et al. A refined symptom-based approach to diagnose pulmonary tuberculosis in children. Pediatrics 2006;118:e1350–1359.PubMedCrossRefGoogle Scholar
  42. 42.
    Hesseling AC, Schaaf HS, Gie RP, Starke JR, Beyers N. A critical review of diagnostic approaches used in the diagnosis of childhood tuberculosis. Int J Tuberc Lung Dis 2002;6:1038–1045.PubMedGoogle Scholar
  43. 43.
    Wong KS, Huang YC, Lai SH, Chiu CY, Huang YH, Lin TY. Validity of symptoms and radiographic features in predicting positive AFB smears in adolescents with tuberculosis. Int J Tuberc Lung Dis 2010;14:155–159.PubMedGoogle Scholar
  44. 44.
    Andronikou S, Joseph E, Lucas S, Brachmeyer S, Du Toit G, Zar H, et al. CT scanning for the detection of tuberculous mediastinal and hilar lymphadenopathy in children. Pediatr Radiol 2004;34:232–236.PubMedCrossRefGoogle Scholar
  45. 45.
    Gómez-Pastrana D, Carceller-Blanchard A. Should pulmonary computed tomography be performed in children with tuberculosis infection without apparent disease? An Pediatr (Barc) 2007;67:585–593.Google Scholar
  46. 46.
    Andronikou S, Vanhoenacker FM, De Backer AI. Advances in imaging chest tuberculosis: blurring of differences between children and adults. Clin Chest Med 2009;30:717–744, viii.PubMedCrossRefGoogle Scholar
  47. 47.
    De Backer AI, Mortelé KJ, Vanhoenacker FM, Parizel PM. Imaging of extraspinal musculoskeletal tuberculosis. Eur J Radiol 2006;57:119–130.PubMedCrossRefGoogle Scholar
  48. 48.
    Singh M, Moosa NV, Kumar L, Sharma M. Role of gastric lavage and broncho-alveolar lavage in the bacteriological diagnosis of childhood pulmonary tuberculosis. Indian Pediatr 2000;37:947–951.PubMedGoogle Scholar
  49. 49.
    Zar HJ, Hanslo D, Apolles P, Swingler G, Hussey G. Induced sputum versus gastric lavage for microbiological confirmation of pulmonary tuberculosis in infants and young children: a prospective study. Lancet 2005;365:130–134.PubMedCrossRefGoogle Scholar
  50. 50.
    Ba F, Rieder HL. A comparison of fluorescence microscopy with the Ziehl-Neelsen technique in the examination of sputum for acid-fast bacilli. Int J Tuberc Lung 1999;3:1101–1105.Google Scholar
  51. 51.
    Steingart KR, Henry M, Ng V, Hopewell PC, Ramsay A, Cunningham J, et al. Fluorescence versus conventional sputum smear microscopy for tuberculosis: a systematic review. Lancet Infect Dis 2006;6:570–581.PubMedCrossRefGoogle Scholar
  52. 52.
    Marais BJ, Brittle W, Painczyk K, Hesseling AC, Beyers N, Wasserman E, et al. Use of light-emitting diode fluorescence microscopy to detect acid-fast bacilli in sputum. Clin Infect Dis 2008;47:203–207.PubMedCrossRefGoogle Scholar
  53. 53.
    Siddiqi S, Ahmed A, Asif S, Behera D, Javaid M, Jani J, et al. Direct drug susceptibility testing of Mycobacterium tuberculosis for rapid detection of multidrug resistance using the Bactec MGIT 960 system: a multicenter study. J Clin Microbiol 2012;50:435–440.PubMedCrossRefGoogle Scholar
  54. 54.
    Kcocagöz T, Altin S, Türkyılmaz Ö, Taş İ, Karaduman P, Bolaban D, et al. Efficiency of TK culture system in the diagnosis of tuberculosis. Diag Microbiol Infect Dis 2012;72:350–357.CrossRefGoogle Scholar
  55. 55.
    Kolk A, Hoelscher M, Maboko L, Jung J, Kuijper S, Cauchi M, et al. Electronic-nose technology using sputum samples in diagnosis of patients with tuberculosis. J Clin Microbiol 2010;48:4235–4238.PubMedCrossRefGoogle Scholar
  56. 56.
    Kim JH, Kim YJ, Ki CS, Kim JY, Lee NY. Evaluation of Cobas TeqMan MTB PCR for detection of mycobacterium tuberculosis. J Clin Microbiol 2011;49:173.PubMedCrossRefGoogle Scholar
  57. 57.
    Boehme CC, Nabeta P, Hillemann D, Nicol MP, Shenai S, Krapp F, et al. Rapid molecular detection of tuberculosis and rifampin resistance. N Engl J Med 2010;363:1005–1015.PubMedCrossRefGoogle Scholar
  58. 58.
    Papaventsis D, Ioannidis P, Karabela S, Nikolaou S, Syridou G, Marinou I, et al. Impact of Gen-Probe Amplified MTD test on tuberculosis diagnosis in children. Int J Tuberc Lung Dis 2012;16:384–389.PubMedCrossRefGoogle Scholar
  59. 59.
    World Health Organization. Molecular line probe assays for rapid screening of patients at risk of multidrug-resistant tuberculosis (MDR-TB). Geneva: World Health Organization, 2008.Google Scholar
  60. 60.
    Graham SM. Treatment of paediatric TB: revised WHO guidelines. Paediatr Respir Rev 2011;12:22–26.PubMedCrossRefGoogle Scholar
  61. 61.
    Schoeman JF, Van Zyl LE, Laubscher JA, Donald PR. Effect of corticosteroids on intracranial pressure, computed tomographic findings, and clinical outcome in young children with tuberculous meningitis. Pediatrics 1997;99:226–231.PubMedCrossRefGoogle Scholar
  62. 62.
    World Health Organization. Rapid advice: treatment of tuberculosis in children. World Health Organization, Geneva, Switzerland, 2010.Google Scholar
  63. 63.
    Jassal MS, Aldrovandi GM. 2050: Ending the odyssey of the great white plague. Pharmacol Res 2011;64:176–17Google Scholar
  64. 64.
    Koul A, Arnoult E, Lounis N, Guillemont J, Andries K. The challenge of new drug discovery for tuberculosis. Nature 2011;469:483–490.PubMedCrossRefGoogle Scholar
  65. 65.
    Nair N. Childhood tuberculosis: public health and contact tracing. Pediatr Respir Rev 2001;2:97–102.CrossRefGoogle Scholar
  66. 66.
    Kochi A, Nunn P, Dye C, Taylor E. Global burden of disease. Lancet 1997;350:142.PubMedCrossRefGoogle Scholar
  67. 67.
    Gandhi NR, Moll A, Sturm AW, Pawinski R, Govender T, Lalloo U, et al. Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa. Lancet 2006;368:1575–1580.PubMedCrossRefGoogle Scholar
  68. 68.
    Guidance for national tuberculosis and HIV programmes on the management of tuberculosis in HIV infected children: recommendations for a public health approach, 2010. Paris: International Union Against Tuberculosis and Lung Disease, 2010.Google Scholar
  69. 69.
    Migliori GB, Sotgiu G, Gandhi NR, Falzon D, Deriemer K, Centis R, et al. Drug resistance beyond XDR-TB: results from a large individual patient data meta-analysis. Eur Respir J 2012; DOI: 10.1183/09031936.00136312.Google Scholar
  70. 70.
    Seddon JA, Godfrey-Faussett P, Hesseling AC, Gie RP, Beyers N, Schaaf HS. Management of children exposed to multidrugresistant Mycobacterium tuberculosis. Lancet Infect Dis 2012;12:469–479.PubMedCrossRefGoogle Scholar
  71. 71.
    Orenstein EW, Basu S, Shah NS, Andrews JR, Friedland GH, Moll AP, et al. Treatment outcomes among patients with multidrug-resistant tuberculosis: systematic review and metaanalysis. Lancet Infect Dis 2009;9:153–161.PubMedCrossRefGoogle Scholar
  72. 72.
    Ettehad D, Schaaf HS, Seddon JA, Cooke GS, Ford N. Treatment outcomes for children with multidrug-resistant tuberculosis: a systematic review and meta-analysis. Lancet Infect Dis 2012;12:449–456.PubMedCrossRefGoogle Scholar
  73. 73.
    Ahuja SD, Ashkin D, Avendano M, Banerjee R, Bauer M, Bayona JN, et al. Multidrug resistant pulmonary tuberculosis treatment regimens and patient outcomes: an individual patient data meta-analysis of 9,153 patients. PLoS Med 2012;9:e1001300.PubMedCrossRefGoogle Scholar
  74. 74.
    Wells CD, Cegielski JP, Nelson LJ, Laserson KF, Holtz TH, Finlay A, et al. HIV infection and multidrug-resistant tuberculosis: the perfect storm. J Infect Dis 2007;196:S86–S107.PubMedCrossRefGoogle Scholar
  75. 75.
    WHO. Guidelines for the programmatic management of drugresistant tuberculosis. Geneva: World Health Organization, 2006. http://whqlibdoc.who.int/publications/2006/9241546956_eng.pdf (accessed June 19, 2008).Google Scholar
  76. 76.
    World Health Organization. Report of the meeting on TB medicines for children-July 2008. World Health Organization, Geneva, 2008. http://who.int/selection_medicines/committes/subcommittee/2/en/index.html (accessed June 19, 2012).Google Scholar
  77. 77.
    American Thoracic Society and Centers for Disease Control and Prevention. Targeted tuberculin testing and treatment of latent tuberculosis infection. MMWR Recomm Rep 2000;49:1–51.Google Scholar
  78. 78.
    Lobue P, Menzies D. Treatment of latent tuberculosis infection: an update. Respirology 2010;15:603–622.PubMedCrossRefGoogle Scholar
  79. 79.
    Comstock G. How much isoniazid is needed for prevention of tuberculosis among immunocompetent adults? Int J Tuberc Lung Dis 1999;3:847–850.PubMedGoogle Scholar
  80. 80.
    Spyridis NP, Spyridis PG, Gelesme A, Sypsa V, Valianatou M, Metsou F, et al. The effectiveness of a 9-month regimen of isoniazid alone versus 3- and 4-month regimens of isoniazid plus rifampin for treatment of latent tuberculosis infection in children: results of an 11-year randomized study. Clin Infect Dis 2007;45:715–722.PubMedCrossRefGoogle Scholar

Copyright information

© Children's Hospital, Zhejiang University School of Medicine and Springer-Verlag Berlin Heidelberg 2013

Authors and Affiliations

  • Shou-Chien Chen
    • 1
    • 2
  • Kwo-Liang Chen
    • 3
  • Kou-Huang Chen
    • 3
  • Shun-Tien Chien
    • 4
  • Kow-Tong Chen
    • 5
    • 6
  1. 1.Department of Family MedicineDa-Chien General HospitalTaiwanChina
  2. 2.General Education CenterTa Tung UniversityTaiwanChina
  3. 3.Department of Industrial Engineering and ManagementChina University of Science and TechnologyTaiwanChina
  4. 4.Chest Hospital, Department of HealthExecutive YuanTaiwanChina
  5. 5.Department of Public Health, College of MedicineNational Cheng Kung UniversityTainanChina
  6. 6.Department of Public Health, College of MedicineNational Cheng-Kung UniversityTaiwanChina

Personalised recommendations